西洛他唑
医学
安慰剂
痴呆
临床痴呆评级
不利影响
临床终点
临床试验
内科学
物理疗法
阿司匹林
疾病
替代医学
病理
作者
Satoshi Saitô,Keisuke Suzuki,Ryo Ohtani,Takakuni Maki,Hisatomo Kowa,Hisatsugu Tachibana,Kazuo Washida,Nobuya Kawabata,Toshiki Mizuno,Rie Kanki,Shinji Sudoh,Hiroshi Kitaguchi,Katsuro Shindo,Akihiro Shindo,Nobuyuki Oka,Keiichi Yamamoto,Fumihiko Yasuno,Chikage Kakuta,Ryosuke Kakuta,Yumi Yamamoto
出处
期刊:JAMA network open
[American Medical Association]
日期:2023-12-04
卷期号:6 (12): e2344938-e2344938
被引量:9
标识
DOI:10.1001/jamanetworkopen.2023.44938
摘要
Recent evidence indicates the efficacy of β-amyloid immunotherapy for the treatment of Alzheimer disease, highlighting the need to promote β-amyloid removal from the brain. Cilostazol, a selective type 3 phosphodiesterase inhibitor, promotes such clearance by facilitating intramural periarterial drainage.
科研通智能强力驱动
Strongly Powered by AbleSci AI